PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Brain and Neuroscience Advances

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Brain and Neuroscience Advances has 1 tracked paper indexed in Blossom (2021) from 3 authors, most often covering Ketamine, across Anxiety Disorders, Depressive Disorders and Schizophrenia.

Published Papers

Open Accessmeta

A continuum hypothesis of psychotomimetic rapid antidepressants

The paper proposes a continuum hypothesis that psychotomimetic rapid antidepressants (ketamine, classical psychedelics and sleep deprivation) produce acute antidepressant effects by increasing the flexibility of prior expectations within a hierarchical predictive coding framework, thereby linking their antidepressant and psychotomimetic actions. It reviews supporting neurobiological and neuromodulatory evidence, contrasts the idea with other antidepressant theories, and proposes experiments to test the hypothesis.

Published
May 3, 2021
Journal
Brain and Neuroscience Advances
Authors
Haarsma, J., Harmer, C. J., Tamm, S.

Quick Facts

Papers Indexed
1
h-Index
1
Publisher
SAGE Publications
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.